Business / Finance

RSS

Beckman Coulter Genomics announces CAP accreditation

Beckman Coulter Genomics, a leading provider of DNA Sequencing Services announces today accreditation from the College of American Pathologists (CAP).

From Beckman Coulter Life Sciences - Automation and Genomics 13 Jan 2015

Digital healthcare communications: an interview with David Hunt, CEO of HAVAS LYNX Europe

Digital has excited the industry, it has hinted at a brighter future, a potential competitive advantage and most importantly a better purpose, however like many others, it has not been the revolution it might have been.

13 Jan 2015

BioLight invests in newly-formed ophthalmic company

BioLight Life Sciences Investments Ltd., a firm that invests in, manages and commercializes biomedical innovations in ophthalmology and cancer diagnostics, today announced its investment in a newly-formed ophthalmic company that has licensed-in a world-wide drug-delivery platform from the Hebrew University, Israel, that has the potential to enable more efficient and safer delivery of eye drops.

12 Jan 2015

MGB Biopharma provides update on business performance for 2014

MGB Biopharma, a biopharmaceutical company developing a truly novel class of anti-infectives, provides an update on its business performance for 2014. MGB Biopharma is developing a pipeline of novel antimicrobials that puts it at the forefront of addressing the major global problem of antimicrobial resistance.

12 Jan 2015

Biogen Idec, Columbia University Medical Center form $30 million genomics research alliance

Biogen Idec and Columbia University Medical Center have formed a $30 million strategic alliance to conduct genetics discovery research on the underlying causes of disease and to identify new treatment approaches. As part of this agreement, a sequencing and analysis facility and shared postdoctoral program will be established at Columbia to support collaborative genetics studies.

11 Jan 2015

Advisory Board announces completion of Royall acquisition

The Advisory Board Company, a global insight-driven technology, research, and services provider, today announced the completion of its acquisition of Royall & Company.

11 Jan 2015

Memorial Prompt Care & Family Medicine becomes MemorialCare Medical Group

Memorial Prompt Care & Family Medicine announced that it has changed its name to MemorialCare Medical Group. Affiliated with the nationally recognized MemorialCare Health System, it was a natural fit for them to become part of the award-winning MemorialCare Medical Group. The name change is effective immediately.

11 Jan 2015

AMN Healthcare acquires Onward Healthcare, Medefis and Locum Leaders from OGH

AMN Healthcare Services, Inc., the nation's leader and innovator in healthcare workforce solutions and staffing services, today announced the completion of the acquisition of Onward Healthcare, Locum Leaders and Medefis from OGH, LLC for a total purchase price of $82.5 million.

11 Jan 2015

Precision NanoSystems, Arcturus Therapeutics partner to develop RNA medicines

Precision NanoSystems, a leader in the development and application of microfluidics for the manufacture of nanomedicines; and, Arcturus Therapeutics, a leading small interfering RNA (siRNA) and messenger RNA (mRNA) drug discovery and development company, today announced a partnership for the manufacture of RNA medicines.

From Precision NanoSystems Inc. 11 Jan 2015

Two leading biotechnology companies collaborate to gain further understanding of Parkinson’s disease

This week 23andMe (a genetic testing company) and Genentech (medical research company of the Roche Group) agreed a collaboration to undertake whole genome sequencing for 3,000 patients with Parkinson’s disease. The genetic information will be collected by 23andMe and used by Genentech to identify new therapeutic targets for treating Parkinson’s disease.

9 Jan 2015

Nuo signs licensing and distribution agreement with Rohto for Aurix wound care system

Nuo Therapeutics, Inc., a pioneer in biodynamic therapies, today announced that it has signed an exclusive licensing and distribution agreement for the Aurix System with Rohto Pharmaceutical Co., Ltd., one of Japan’s leading pharmaceutical, health and wellness companies.

9 Jan 2015

DiaCarta raises $8 million in Series A financing from BVCF

DiaCarta, Inc., a privately-held biotechnology company raised $8 million in Series A financing from BVCF (BioVeda China Fund). Proceeds from Series A financing will be used to expand the product portfolio and support global commercialization. Dr. Weixin Xu of BVCF will join DiaCarta board of directors.

9 Jan 2015

Crown Bioscience to double capacity of PRECOS facility, rename UK site

Crown Bioscience, Inc., a leading global drug discovery and development service company, has announced that it will double the capacity of the recently acquired PRECOS (Preclinical Oncology Services Limited) facility and will rename the site Crown Bioscience UK Ltd.

9 Jan 2015

MTF Wound Care division inks group purchasing deal with Premier

The Musculoskeletal Transplant Foundation Wound Care division announced today that it has signed a group purchasing agreement with Premier, Inc., a leading healthcare improvement company. The agreement offers Premier alliance members access to MTF Wound Care's innovative line of biologic tissue forms.

8 Jan 2015

H&P Labs announces licensing agreement to develop oral drug therapy against Ebola

H&P Labs Inc. announced an agreement with Harvard University and Brigham and Women's Hospital to license two classes of compounds in order to develop an oral drug therapy against Ebola.

8 Jan 2015

Helsinn, Pharmacosmos sign license agreement for commercialization of Monofer in the US

Helsinn Group and Pharmacosmos A/S today jointly announce that they have entered into an agreement for the exclusive US commercialization rights to Monofer, an innovative intravenous iron replacement therapy under development for the treatment of Iron Deficiency Anemia.

8 Jan 2015

Sciformix opens new European office in Manchester, UK

Sciformix Corporation, a leading Scientific Process Organization, has opened a new office in Manchester, UK expanding its global presence and footprint to include the European region.

8 Jan 2015

Carl Zeiss Meditec to invest in Oraya Therapy for treatment of wet AMD

Carl Zeiss Meditec AG and Oraya Therapeutics, Inc. jointly announced today that the companies have entered into a collaboration agreement under which Carl Zeiss Meditec will provide funding to Oraya over a period of up to two years for the implementation of Oraya’s growth strategy, and in turn receive rights in the company reaching up to a majority stake after two years.

8 Jan 2015

Ferrer partners with Cipher Pharmaceuticals to bring Ozenoxacin to the Canadian market

Ferrer, a privately-held Spanish pharmaceutical company, today announces that it has licensed commercialisation rights for Ozenoxacin one per cent cream in Canada to Cipher Pharmaceuticals Inc.

8 Jan 2015

Kyowa Hakko Kirin and Syndax sign agreement to develop entinostat in Japan and Korea

Kyowa Hakko Kirin Co., Ltd., (Headquarters: Chiyoda-ku, Tokyo; president and CEO: Nobuo Hanai, "Kyowa Hakko Kirin") and Syndax Pharmaceuticals, Inc., (Waltham, Mass.; president and CEO: Arlene M. Morris, "Syndax") today jointly announced that the companies have entered into a license agreement for the exclusive rights to develop and commercialize entinostat in Japan and Korea.

7 Jan 2015

Business / Finance

Beckman Coulter Genomics announces CAP accreditation

Digital healthcare communications: an interview with David Hunt, CEO of HAVAS LYNX Europe

BioLight invests in newly-formed ophthalmic company

MGB Biopharma provides update on business performance for 2014

Biogen Idec, Columbia University Medical Center form $30 million genomics research alliance

Advisory Board announces completion of Royall acquisition

Memorial Prompt Care & Family Medicine becomes MemorialCare Medical Group

AMN Healthcare acquires Onward Healthcare, Medefis and Locum Leaders from OGH

Precision NanoSystems, Arcturus Therapeutics partner to develop RNA medicines

Two leading biotechnology companies collaborate to gain further understanding of Parkinson’s disease

Nuo signs licensing and distribution agreement with Rohto for Aurix wound care system

DiaCarta raises $8 million in Series A financing from BVCF

Crown Bioscience to double capacity of PRECOS facility, rename UK site

MTF Wound Care division inks group purchasing deal with Premier

H&P Labs announces licensing agreement to develop oral drug therapy against Ebola

Helsinn, Pharmacosmos sign license agreement for commercialization of Monofer in the US

Sciformix opens new European office in Manchester, UK

Carl Zeiss Meditec to invest in Oraya Therapy for treatment of wet AMD

Ferrer partners with Cipher Pharmaceuticals to bring Ozenoxacin to the Canadian market

Kyowa Hakko Kirin and Syndax sign agreement to develop entinostat in Japan and Korea

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Latest News